LONsurf and G-CSF Use: Being On A Right Dose-intensity to Optimize Treatment Efficacy

Summary

Prospective cohort of patients treated with trifluridine/tipiracil, maximal sample size 250 patients. It is expected, that 89 patients will experience a grade 3-4 neutropenia and will be included in the phase II.

Timeline

Start

2020-05-20

Primary completion

2023-11-10

Completion

2025-11

Drugs

Indications